The Queen's University of Belfast (2013) US Patent - Liposomal delivery system. 14/385,367.

	Text (FULLTEXT) C-20.pdf Download (7MB)
	Text (PEER REVIEW) C-20 Rev.pdf Download (1MB)
	Text (PEER REVIEW) Liposomal Delivery System.pdf Download (10MB)

Abstract

The present invention is directed to a liposomal delivery system comprising defined lipid components, including dimethyldioctadecylammonium and other lipid components and a stabilizing agent, which may be used in the delivery of bioactive agents to a subject in need thereof. The liposomal delivery system of the invention provide improvements in terms of delivery and stability. Ideally, the liposomal delivery system is used as a vaccine or drug/medicament delivery system although other bioactive agents may be delivered

Item Type:	Patent
Subjects:	R Medicine R Medicine > RS Pharmacy and materia medica
Divisions:	05. Fakultas Farmasi
Creators:	Creators NIM Victoria Kett UNSPECIFIED Helmy Yusuf, NIDN. 0015077901 UNSPECIFIED Helen McCarthy UNSPECIFIED Kun Hung Chen UNSPECIFIED
Depositing User:	Mr M. Fuad Sofyan
Date Deposited:	19 Aug 2019 01:42
Last Modified:	21 Aug 2019 00:10
URI:	http://repository.unair.ac.id/id/eprint/85792
Sosial Share:

Actions (login required)

View Item